HIGH UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引:0
|
作者
FRADE, LJG [1 ]
AVELLO, AG [1 ]
SUREDA, A [1 ]
LARANA, JG [1 ]
TORRADO, MC [1 ]
机构
[1] UNIV ALCALA DE HENARES, HOSP RAMON & CAJAL, DEPT HEMATOL, ALCALA DE HENARES, SPAIN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1336 / 1336
页数:1
相关论文
共 50 条
  • [41] EPIDERMAL GROWTH-FACTOR (EGF) STIMULATION OF UROKINASE TYPE PLASMINOGEN-ACTIVATOR (U-PA) ACTIVITY IN CORNEAL EPITHELIAL-CELLS
    MORIMOTO, K
    MISHIMA, M
    NISHIDA, T
    OTORI, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 954 - 954
  • [42] PLASMA-CONCENTRATIONS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND ITS RECEPTOR (U-PAR) IN LIVER AND PROSTATE-CANCER
    PARAMO, JA
    HERRERO, I
    ROBLES, JE
    HERMIDA, J
    RIFON, J
    ROCHA, E
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1290 - 1290
  • [43] COMPARATIVE THROMBOLYTIC PROPERTIES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA), SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND K1K2PU (A T-PA/U-PA CHIMERA) IN A COMBINED ARTERIAL AND VENOUS THROMBOSIS MODEL IN THE DOG
    LU, HR
    WU, ZM
    PAUWELS, P
    LIJNEN, HR
    COLLEN, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) : 1350 - 1359
  • [44] A HYBRID PLASMINOGEN-ACTIVATOR BINDS TO THE U-PA RECEPTOR AND HAS A REDUCED THROMBOLYTIC POTENCY INVIVO
    ASSELBERGS, FAM
    BURGI, R
    HAMERMAN, J
    HEIM, J
    VANOOSTRUM, J
    AGNELLI, G
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (01) : 50 - 55
  • [45] Decrease in urokinase-type plasminogen activator (u-PA) levels in patients with non-insulin dependent diabetes mellitus
    Krekora, K
    Vitacolonna, E
    DiCastelnuovo, A
    DOrazio, A
    DeLucia, D
    Dooijewaard, G
    Capani, F
    Donati, MB
    Iacoviello, L
    FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (04): : 215 - 219
  • [46] A BISPECIFIC MONOCLONAL-ANTIBODY AGAINST HUMAN FIBRIN AND AGAINST UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ENHANCES CLOT LYSIS BY U-PA IN ANIMAL-MODELS OF VENOUS THROMBOSIS
    STASSEN, JM
    KUROKAWA, T
    IWASA, S
    KAKINUMA, A
    LIJNEN, HR
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 788 - 788
  • [47] UROKINASE PLASMINOGEN-ACTIVATOR AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN BREAST-CANCER
    DUGGAN, C
    MAGUIRE, T
    MCDERMOTT, E
    OHIGGINS, N
    FENNELLY, JJ
    DUFFY, MJ
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) : 597 - 600
  • [48] Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system
    Ries, M
    Zenker, M
    Gaffney, PJ
    THROMBOSIS RESEARCH, 2000, 100 (04) : 341 - 351
  • [49] THE KINETICS OF INHIBITION OF TISSUE-TYPE (T-PA) AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) BY 2 MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR 2 (PAI-2) - THE INFLUENCE OF FIBRIN
    THORSEN, S
    MADSEN, B
    RODER, M
    LECANDER, I
    ASTEDT, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 350 - 350
  • [50] THE RELEASE OF PLASMINOGEN ACTIVATORS (T-PA AND U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AFTER VENOUS STASIS
    FALKON, L
    GARI, M
    BORRELL, M
    FONTCUBERTA, J
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (01) : 33 - 38